FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(079937015)" | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2500 ug/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-684 | 70092-684-48 | Fentanyl Citrate | 1500 ug/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2750 ug/55 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Fentanyl Citrate; Bupivacaine Hydrochloride | 6000 ug/3000 mL; 3750 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 250 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 312.5 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Fentanyl Citrate; Bupivacaine Hydrochloride | 6000 ug/3000 mL; 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-004 | 70092-004-37 | Amiodarone | 450 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-005 | 70092-005-38 | Amiodarone | 900 mg/500 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Fentanyl Citrate; Ropivacaine Hydrochloride | 6000 ug/3000 mL; 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Fentanyl Citrate; Ropivacaine Hydrochloride | 6000 ug/3000 mL; 6000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 200 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-207 | 70092-207-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Amiodarone | 5400 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | Heparin Sodium | 3000 U/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-216 | 70092-216-50 | Heparin Sodium | 50 U/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-217 | 70092-217-47 | Heparin Sodium | 20 U/20 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-281 | 70092-281-08 | Heparin Sodium | 30000 U/1000 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-686 | 70092-686-48 | Hydromorphone Hydrochloride | 15 mg/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-294 | 70092-294-74 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 15 mg/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Hydromorphone Hydrochloride | 1500 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-687 | 70092-687-48 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 20 mg/2 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Ketorolac Tromethamine; Epinephrine; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 900 mg/3000 mL; 15 mg/3000 mL; 2.4 mg/3000 mL; 7380 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Epinephrine; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 15 mg/50 mL; .25 mg/50 mL; .04 mg/50 mL; 123 mg/50 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-175 | 70092-175-46 | Lidocaine Hydrochloride | 91 mg/10 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | Lidocaine Hydrochloride | 30000 mg/3000 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-443 | 70092-443-43 | Lidocaine Hydrochloride | 9.1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-611 | 70092-611-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL | 2025-1 | valid | 2026-10-17 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-1 | valid | 2026-10-17 |